Microbot Medical Inc Stock

$3.81

0.00% day before yesterday

Nasdaq, Aug 30, 01:56 am CET

ISIN

US59503A1051

Symbol

MBOT

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Overview Dividends Analysts Charts News Strategies

Microbot Medical Inc Stock price

$3.81

-2.91 43.30% 5Y

Nasdaq, Closing price Fri, Aug 29 2025

-0.19 4.75%

ISIN

US59503A1051

Symbol

MBOT

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Key metrics

Basic

Market capitalization

$173.5m

Enterprise Value

$140.9m

Net debt

positive

Cash

$32.7m

Shares outstanding

38.0m

Valuation (TTM | estimate)

P/E

negative | negative

P/S

- | 104.3

EV/Sales

- | 84.7

EV/FCF

negative

P/B

5.7

Financial Health

Equity Ratio

58.5%

Return on Equity

-324.2%

ROCE

-43.3%

ROIC

Debt/Equity

0.0

Financials (TTM | estimate)

Revenue

$0.0 | $1.7m

EBITDA

$-13.1m | -

EBIT

$-13.2m | $-11.8m

Net Income

$-12.7m | $-13.2m

Free Cash Flow

$-9.9m

EPS

$-0.3

FCF per Share

$-0.3

Short interest

17.1%

Employees

Rev per Employee

$0.0

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Get Started for Free Today

Microbot Medical Inc Stock Analysis

Unlock Scores for Free

??

7 Analysts have issued a Microbot Medical Inc forecast:

6x Buy

86%

More details on Analyst Estimates Including Price Targets

7 Analysts have issued a Microbot Medical Inc forecast:

Buy

86%

Hold

14%

Analyst Estimates with Stock Price Targets

Financial data from Microbot Medical Inc

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '25		+/- %
Revenue	- -	- 100%
- Direct Costs	- -	- -
Gross Profit	- -	- -
- Selling and Administrative Expenses	5.86 5.86	40% 40% -
- Research and Development Expense	7.61 7.61	43% 43% -
EBITDA	-13 -13	24% 24% -
- Depreciation and Amortization	0.08 0.08	20% 20% -
EBIT (Operating Income) EBIT	-13 -13	24% 24% -
Net Profit	-13 -13	22% 22% -

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Microbot Medical Inc Stock News

Positive

Seeking Alpha

●

4 days ago

Microbot Medical: LIBERTY's Disposable Endovascular Robot Nears FDA Catalyst

MBOT's main value driver is its LIBERTY robot. This is a disposable, portable endovascular robot that has great potential. LIBERTY showed strong ACCESS-PVI data and now awaits FDA 510(k) clearance for a tentative US launch. If approved, MBOT could generate revenues from selling this robot, plus some miscellaneous per-procedure consumables.

Neutral

GlobeNewsWire

●

12 days ago

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

With the Newly Granted IP, the Company's IP Portfolio for the LIBERTY ® System now includes 12 patents granted globally and 57 patent applications pending.

Neutral

GlobeNewsWire

●

27 days ago

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

HINGHAM, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced it has been approved to receive a non-dilutive grant from the Israel Innovation Authority ("IIA”) in the amount of NIS 2.15 Million (approximately $630,000 at a recent exchange rate).

More Microbot Medical Inc News

Company Profile

Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.

Head office	United States
CEO	Harel Gadot
Employees	20
Founded	1988
Website	www.microbotmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now